ASCO's 2025 guidelines recommend a more selective approach to surgery for pleural mesothelioma, limiting surgical intervention to early-stage epithelioid cases at specialized centers.
Leading gastroenterologist Dr. David Rubin will provide expert insights on the ulcerative colitis treatment landscape and discuss Abivax's ABTECT Phase 3 trial of obefazimod.